{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:24:03Z","timestamp":1755599043067,"version":"3.41.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Since November 2021, a new variant of concern (VOC), the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage B.1.1.529 (Omicron) has emerged as the dominant coronavirus disease 2019 (COVID-19) infection worldwide. We describe the clinical presentation, risk factors, and outcomes in a cohort of kidney and kidney pancreas transplant recipients with COVID-19 caused by Omicron infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We included all kidney and kidney pancreas transplant recipients diagnosed with SARS-CoV-2 Omicron infections between December 26, 2021, and January 14, 2022, in a single transplant center in Australia. Identification of the VOC Omicron was confirmed using phylogenetic analysis of SARS-CoV-2 sequences.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Forty-one patients with kidney (6 living and 33 deceased) and kidney pancreas transplants were diagnosed with the VOC Omicron (lineage B.1.1.529\/BA.1) infection during the study period. The mean age (SD) at the time of diagnosis was 52 (11.1) y; 40 (out of 41) (98%) had received at least 2 doses of COVID-19 vaccine. Cough was the most frequent symptom (80.5%), followed by myalgia (70.7%), sore throat (63.4%), and fever (58.5%). After a follow-up time of 30 d, 1 (2.4%) patient died, 2 (4.9%) experienced multiorgan failure, and 5 (12.2%) had respiratory failure; 11 (26.8%) patients developed other superimposed infections. Compared with recipients who did not receive sotrovimab antibody therapy, the odds ratio (95% confidence interval) for hospitalization among patients who received sotrovimab was 0.05 (0.005-0.4).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Despite double or triple dose vaccination, VOC Omicron infections in kidney and kidney pancreas transplant recipients are not necessarily mild. Hospitalization rates remained high (around 56%), and sotrovimab use may prevent hospitalization.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004203","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T19:00:07Z","timestamp":1654714807000},"page":"1860-1866","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes"],"prefix":"10.1097","volume":"106","author":[{"given":"Germaine","family":"Wong","sequence":"first","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Camperdown, NSW, Australia."},{"name":"Centre for Transplant and Renal Research, Westmead Hospital, NSW, Australia."},{"name":"Centre for Kidney Research, Kids Research Institute, The Children\u2019s Hospital at Westmead, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Rowlandson","sequence":"additional","affiliation":[{"name":"Centre for Transplant and Renal Research, Westmead Hospital, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharshana","family":"Sabanayagam","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Camperdown, NSW, Australia."},{"name":"Centre for Transplant and Renal Research, Westmead Hospital, NSW, Australia."},{"name":"Centre for Kidney Research, Kids Research Institute, The Children\u2019s Hospital at Westmead, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew N.","family":"Ginn","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Australia."},{"name":"Institute of Clinical Pathology and Medical Research, Westmead Hospital and University of Sydney, Westmead, NSW, Australia."},{"name":"Faculty of Medicine and Health, University of Sydney, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Kable","sequence":"additional","affiliation":[{"name":"Centre for Transplant and Renal Research, Westmead Hospital, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederika","family":"Sciberras","sequence":"additional","affiliation":[{"name":"Centre for Transplant and Renal Research, Westmead Hospital, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Au","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Camperdown, NSW, Australia."},{"name":"Centre for Transplant and Renal Research, Westmead Hospital, NSW, Australia."},{"name":"Centre for Kidney Research, Kids Research Institute, The Children\u2019s Hospital at Westmead, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Draper","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Arnott","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitali","family":"Sintchenko","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic E.","family":"Dwyer","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon C.A.","family":"Chen","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen","family":"Kok","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"R1-20250604","article-title":"Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.","author":"Syed","year":"2022","journal-title":"medRxiv"},{"key":"R2-20250604","first-page":"8012","article-title":"Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.","volume":"25","author":"Meo","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet"},{"key":"R4-20250604","first-page":"M22-0308","article-title":"Comparison of patients infected with Delta versus Omicron COVID-19 variants presenting to Paris emergency departments: a retrospective cohort study.","author":"Bouzid","year":"2022","journal-title":"Ann Intern Med"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/jama.2021.24868","article-title":"Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves.","volume":"327","author":"Maslo","year":"2022","journal-title":"JAMA"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"217","DOI":"10.15585\/mmwr.mm7106e2","article-title":"Clinical characteristics and outcomes among adults hospitalized with laboratory-confirmed SARS-CoV-2 infection during periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant predominance - one hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.","volume":"71","author":"Modes","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2021.07.003","article-title":"Incidence and outcomes of COVID-19 in people with CKD: a systematic review and meta-analysis.","volume":"78","author":"Chung","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cmi.2021.09.036","article-title":"Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.","volume":"28","author":"Galmiche","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients.","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mRNA covid-19 vaccine in solid-organ transplant recipients.","volume":"385","author":"Kamar","year":"2021","journal-title":"N Engl J Med"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"e13705","DOI":"10.1111\/tid.13705","article-title":"Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.","volume":"23","author":"Aslam","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"e0104621","DOI":"10.1128\/JCM.01046-21","article-title":"SARS-CoV-2 Genome sequencing methods differ in their abilities to detect variants from low-viral-load samples.","volume":"59","author":"Lam","year":"2021","journal-title":"J Clin Microbiol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"e2952","DOI":"10.1093\/cid\/ciaa1579","article-title":"Cell-based culture informs infectivity and safe de-isolation assessments in patients with coronavirus disease 2019.","volume":"73","author":"Basile","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41591-020-1000-7","article-title":"Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.","volume":"26","author":"Rockett","year":"2020","journal-title":"Nat Med"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"veab064","DOI":"10.1093\/ve\/veab064","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool.","volume":"7","author":"O\u2019Toole","year":"2021","journal-title":"Virus Evol"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","article-title":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.","volume":"5","author":"Rambaut","year":"2020","journal-title":"Nat Microbiol"},{"key":"R17-20250604","first-page":"151178","article-title":"Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients.","volume":"131","author":"Stock","year":"2021","journal-title":"J Clin Invest"},{"key":"R18-20250604","first-page":"8019","article-title":"Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.","volume":"25","author":"Kannan","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"105253","DOI":"10.1016\/j.antiviral.2022.105253","article-title":"The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.","volume":"198","author":"Abdelnabi","year":"2022","journal-title":"Antiviral Res"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"e069761","DOI":"10.1136\/bmj-2021-069761","article-title":"Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.","volume":"376","author":"Lauring","year":"2022","journal-title":"BMJ"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/TP.0000000000004059","article-title":"Real-world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against SARS-CoV-2 in solid organ and Islet transplant recipients.","volume":"106","author":"Callaghan","year":"2022","journal-title":"Transplantation"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"e0265130","DOI":"10.1371\/journal.pone.0265130","article-title":"Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre.","volume":"17","author":"Chukwu","year":"2022","journal-title":"PLoS One"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jamainternmed.2021.7372","article-title":"Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients: a randomized clinical trial.","volume":"182","author":"Reindl-Schwaighofer","year":"2022","journal-title":"JAMA Intern Med"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients.","volume":"385","author":"Hall","year":"2021","journal-title":"N Engl J Med"},{"key":"R26-20250604","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.17020","article-title":"Neutralization against Omicron variant in transplant recipients after three-doses of mRNA vaccine.","author":"Kumar","year":"2022","journal-title":"Am J Transplant"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","article-title":"Early treatment for covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab.","volume":"385","author":"Gupta","year":"2021","journal-title":"N Engl J Med"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(21)02844-0","article-title":"Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.","volume":"399","author":"Dejnirattisai","year":"2022","journal-title":"Lancet"},{"key":"R29-20250604","first-page":"2021.03.09.434607","article-title":"The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2.","author":"Cathcart","year":"2021","journal-title":"bioRxiv"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMc2120219","article-title":"Resistance mutations in SARS-CoV-2 delta variant after sotrovimab use.","volume":"386","author":"Rockett","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:01:49Z","timestamp":1749063709000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004203","relation":{},"ISSN":["0041-1337"],"issn-type":[{"type":"print","value":"0041-1337"}],"subject":[],"published":{"date-parts":[[2022,8,19]]}}}